Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude Children's Research Hospital scientists. Many diseases, including cancers, ...
An international study reports that the combination of two drugs could significantly retard the development of a dangerous form of prostate cancer in men who have specific mutations in DNA repair ...
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia (AML) overcome resistance to one of the most ...
NEW YORK, Aug. 29, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today announced its approval of a subcutaneous formulation of Leqembi (lecanemab), branded as Leqembi Iqlik, for ...
(L) First and co-corresponding author Charlie Wright, PhD, St. and (R) co-corresponding author Paul Geeleher, PhD, both of the St. Jude Department of Computational Biology. (MEMPHIS, Tenn. – December ...